You are here

Nánási Péter Pál

Nánási Péter Pál

Nánási Péter Pál
Name: Nánási Péter Pál

Publication list

Uploaded publications:
16
Publications in DEA:
16
OA:
11
Date range:
2011-2022
2022
  1. Bosire, R., Fadel, L., Mocsár, G., Nánási, P., Sen, P., Sharma, A., Naseem, M., Kovács, A., Kugel, J., Kroemer, G., Vámosi, G., Szabó, G.: Doxorubicin impacts chromatin binding of HMGB1, Histone H1 and retinoic acid receptor.
    Sci. Rep. 12 (1), 1-14, 2022.
    Journal metrics:
    D1 Multidisciplinary (2021)
  2. Imre, L., Niaki, E., Bosire, R., Nánási, P., Nagy, P., Bacsó, Z., Hamidova, N., Pommier, Y., Jordan, A., Szabó, G.: Nucleosome destabilization by polyamines.
    Arch. Biochem. Biophys. 722 1-11, 2022.
    Journal metrics:
    Q2 Biochemistry (2021)
    Q1 Biophysics (2021)
    Q3 Molecular Biology (2021)
2021
  1. Káldy, J., Patakiné Várkonyi, E., Fazekas, G., Nagy, Z., Jakabné Sándor, Z., Bogár, K., Kovács, G., Molnár, M., Lázár, B., Goda, K., Gyöngy, Z., Ritter, Z., Nánási, P., Horváth, Á., Ljubobratović, U.: Effects of Hydrostatic Pressure Treatment of Newly Fertilized Eggs on the Ploidy Level and Karyotype of Pikeperch Sander lucioperca (Linnaeus, 1758).
    Life (Basel). 11 (12), 1-11, 2021.
    Journal metrics:
    Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
    Q2 Ecology, Evolution, Behavior and Systematics
    Q2 Paleontology
    Q3 Space and Planetary Science
  2. Fülöp, G., Oláh, A., Csípő, T., Kovács, Á., Pórszász, R., Veress, R., Horváth, B., Nagy, L., Bódi, B., Fagyas, M., Helgadottir, S., Bánhegyi, V., Juhász, B., Bombicz, M., Priksz, D., Nánási, P., Merkely, B., Édes, I., Csanádi, Z., Papp, Z., Radovits, T., Tóth, A.: Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans.
    Basic Res. Cardiol. 116 (1), 24, 2021.
    Journal metrics:
    Q1 Cardiology and Cardiovascular Medicine
    Q1 Physiology
    Q1 Physiology (medical)
2020
  1. Henn, L., Szabó, A., Imre, L., Román, Á., Ábrahám, A., Vedelek, B., Nánási, P., Boros, I.: Alternative linker histone permits fast paced nuclear divisions in early Drosophila embryo.
    Nucleic Acids Res. 48 (16), 9007-9018, 2020.
    Journal metrics:
    D1 Genetics
  2. Firouzi Niaki, E., Van Acker, T., Imre, L., Nánási, P., Tarapcsák, S., Bacsó, Z., Vanhaecke, F., Szabó, G.: Interactions of Cisplatin and Daunorubicin at the Chromatin Level.
    Sci. Rep. 10 (1), 1-12, 2020.
    Journal metrics:
    D1 Multidisciplinary
2019
2018
  1. Hegedűs, É., Kókai, E., Nánási, P., Imre, L., Halász, L., Jossé, R., Antunovics, Z., Webb, M., El Hage, A., Pommier, Y., Székvölgyi, L., Dombrádi, V., Szabó, G.: Endogenous single-strand DNA breaks at RNA polymerase II promoters in Saccharomyces cerevisiae.
    Nucleic Acids Res. 46 (20), 10649-10668, 2018.
    Journal metrics:
    D1 Genetics
  2. Nánási, P., Komáromi, I., Gaburjakova, M., Almássy, J.: Omecamtiv Mecarbil: a Myosin Motor Activator Agent with Promising Clinical Performance and New in vitro Results.
    Curr. Med. Chem. 25 (15), 1720-1728, 2018.
    Journal metrics:
    Q2 Biochemistry
    Q1 Drug Discovery
    Q2 Molecular Medicine
    Q1 Organic Chemistry
    Q2 Pharmacology
  3. Nánási, P., Komáromi, I., Almássy, J.: Perspectives of a myosin motor activator agent with increased selectivity.
    Can. J. Physiol. Pharmacol. 96 (7), 676-680, 2018.
    Journal metrics:
    Q2 Medicine (miscellaneous)
    Q2 Pharmacology
    Q3 Physiology
    Q3 Physiology (medical)
2017
  1. Imre, L., Simándi, Z., Horváth, A., Fenyőfalvi, G., Nánási, P., Firouzi Niaki, E., Hegedűs, É., Bacsó, Z., Weyemi, U., Mauser, R., Ausio, J., Jeltsch, A., Bonner, W., Nagy, L., Kimura, H., Szabó, G.: Nucleosome stability measured in situ by automated quantitative imaging.
    Sci Rep. 7 (1), 1-15, 2017.
    Journal metrics:
    D1 Multidisciplinary
  2. Nánási, P., Gaburjakova, M., Gaburjakova, J., Almássy, J.: Omecamtiv mecarbil activates ryanodine receptors from canine cardiac but not skeletal muscle.
    Eur. J. Pharmacol. 809 73-79, 2017.
    Journal metrics:
    Q2 Pharmacology
2016
  1. Nánási, P., Váczi, K., Papp, Z.: The myosin activator omecamtiv mecarbil: a promising new inotropic agent.
    Can. J. Physiol. Pharmacol. 94 (10), 1033-1039, 2016.
    Journal metrics:
    Q2 Medicine (miscellaneous)
    Q3 Pharmacology
    Q3 Physiology
    Q3 Physiology (medical)
2011
  1. Nánási, P., Nánási, P.: Problems with class 3 antiarrhythmic agents: conclusions of the past - perspectives of the future.
    Curr. Topics Pharmacol. 15 (2), 11-18, 2011.
    Journal metrics:
    Q4 Pharmacology
    Q4 Pharmacology (medical)
updated: 2023-01-29, 01:31

SCImago quartiles of
scientific journal articles

Number of scientific articles: 16
Q1/D1 7 (43.8%)
Q1 10 (62.5%)
Q2 4 (25%)
Q4 1 (6.3%)
N/A 1 (6.3%)
-
OK

SCImago subject areas and categories

Biochemistry, Genetics and Molecular Biology (8)
Physiology (3)
Biochemistry (2)
Genetics (2)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (1)
Biophysics (1)
Molecular Biology (1)
Molecular Medicine (1)
Multidisciplinary (5)
Multidisciplinary (5)
Pharmacology, Toxicology and Pharmaceutics (5)
Pharmacology (5)
Drug Discovery (1)
Medicine (4)
Physiology (medical) (3)
Medicine (miscellaneous) (2)
Cardiology and Cardiovascular Medicine (1)
Pharmacology (medical) (1)
Agricultural and Biological Sciences (1)
Ecology, Evolution, Behavior and Systematics (1)
Chemistry (1)
Organic Chemistry (1)
Earth and Planetary Sciences (1)
Paleontology (1)
Space and Planetary Science (1)

Genre chart

Year chart

Language chart

iDEa co-authors

Show more

Other co-authors

Show more
Helgadottir, Solveig Lind
Jakabné Sándor Zsuzsanna
Ljubobratović, Uroš
Niaki, Erfaneh Firouzi
Patakiné Várkonyi Eszter